2 results
Approved WMOCompleted
Main objective of the study is to shift rhythms in late chronotypes and thereby lengthen sleep on workdays and align endogenous rhythms
Approved WMOCompleted
To determine the activity (as measured by objective response rate by RECIST1.1) of monalizumab and trastuzumab in patients with metastatic HER2-positive breast cancer.